Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

14.36 +0.36 (+2.57%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
Forecasting The Future: 9 Analyst Projections For Tandem Diabetes Care
 
Via Benzinga
Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry
Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest strain. Large biopharma firms remain protected, while medtech companies... 
Via Benzinga
Topics Government World Trade
Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025
From Tandem Diabetes Care, Inc.
Via Business Wire
The Analyst Verdict: Tandem Diabetes Care In The Eyes Of 4 Experts
 
Via Benzinga
Earnings Scheduled For February 26, 2025
 
Via Benzinga
Unveiling 8 Analyst Insights On Tandem Diabetes Care
 
Via Benzinga
3 Reasons to Sell TNDM and 1 Stock to Buy Instead
Shareholders of Tandem Diabetes would probably like to forget the past six months even happened. The stock dropped 54.1% and now trades at $20.22. This was partly driven by its softer quarterly results... 
Via StockStory
Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
From Tandem Diabetes Care, Inc.
Via Business Wire
The Analyst Verdict: Tandem Diabetes Care In The Eyes Of 5 Experts
 
Via Benzinga
3 Healthcare Stocks Walking a Fine Line
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
This H.B. Fuller Company Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
 
Via Benzinga
Which stocks are experiencing notable movement on Thursday?
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. 
Via Chartmill
Which stocks are moving on Thursday?
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
These stocks are gapping in today's session
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
Tandem Diabetes Crashes 32% As Light Outlook Rattles Pump-Maker's Shares
Shares hit their lowest point since January 2024 after the stock market opened Thursday. 
Via Investor's Business Daily
Get insights into the top gainers and losers of Thursday's pre-market session.
Wondering what's happening in Thursday's pre-market session? Find an overview in this article. 
Via Chartmill
These stocks are moving in today's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
Tandem Diabetes’s (NASDAQ:TNDM) Q4 Sales Beat Estimates But Stock Drops 12.2%
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 35% year on year to $282.6 million. The company expects next quarter’s... 
Via StockStory
Topics Earnings
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes (TNDM) Q4 Earnings: What To Expect
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s what to expect. 
Via StockStory
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
From Tandem Diabetes Care, Inc.
Via Business Wire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.